Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Emerging Competitors in the SUI Market

Executive Summary

The sheer size of the stress urinary incontinence market and the potential for future growth have attracted the attention of a number of emerging companies. Although investor interest has waxed and waned over the years, it appears to be heating up once again. This renewed interest is being driven in part by the push to develop efffective nonsurgical treatments that will appeal to an increasingly health-savvy patient population.
Advertisement

Related Content

Women's Health: Building Interventional Gynecology
Women's Health: Building Interventional Gynecology
Building Interventional Gynecology
Building Interventional Gynecology
Women's Health: Breaking the Incontinence Barrier
Women's Health: Breaking the Incontinence Barrier
Endogun Medical Systems Ltd.
Mpathy Medical Devices Ltd.
Novasys: Using Clinical Trials to Drive Adoption for Incontinence
Novasys: Using Clinical Trials to Drive Adoption for Incontinence

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT035210

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel